Identification of Genetic Basis of Atrioventricular Conduction Defects: From Congenital Forms to Degenerative Forms

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Genetic
Study Type: Observational
SUMMARY

Identification of genes involved in congenital atrioventricular block and progressive Cardiac Conduction Disease.

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: Accepts Healthy Volunteers
View:

• Patients with idiopathic congenital atrioventricular block diagnosed before the age of 15 years.

• Non-immune congenital atrioventricular block documented by a maternal serology (negative for anti-nuclear antibodies or anti Ro-SSA antibodies and anti La-SSB antibodies)

• Written consent to participate to the study and written consent of both parents.

• Parents of children with idiopathic congenital atrioventricular block.

• Patients with isolated cardiac conduction disorder with a normal morphology of the heart confirmed by echocardiography.

• Relatives of patients with isolated cardiac conduction disorder

• Written consent to participate to the study

Locations
Other Locations
France
Chu Nantes
Recruiting
Nantes
Chu Rennes
Recruiting
Rennes
Contact Information
Primary
vincent PROBST, MD-PHD
vincent.probst@chu-nantes.fr
Time Frame
Start Date: January 2011
Estimated Completion Date: December 2021
Participants
Target number of participants: 2600
Treatments
Patients with congenital atrioventricular block
Patient with congenital atrioventricular block
relatives with congenital atrioventricular block
Normal relatives of patients with congenital atrioventricular block
Patients with progressive Cardiac Conduction Disease
Patients with progressive Cardiac Conduction Disease,
relatives with progressive Cardiac Conduction disesae
Normal relatives of patients with progressive Cardiac Conduction Disease
Sponsors
Leads: Nantes University Hospital

This content was sourced from clinicaltrials.gov

Similar Clinical Trials